Loading
institutionsInstitution
Juravinski Cancer Centre / Escarpment Cancer Research Institute
Hamilton's regional cancer centre with McMaster University, home of the trials that made hypofractionated breast radiotherapy standard and of brain tumour stem cell research.
Also called: JCCHamilton Health Sciences cancer program
Overview
The Juravinski Cancer Centre is the tertiary cancer centre of Hamilton Health Sciences and McMaster University, serving south-central Ontario, with the Escarpment Cancer Research Institute as its research arm. The Ontario Clinical Oncology Group at McMaster, founded by Mark Levine, ran pragmatic trials that changed practice, above all Tim Whelan's trial showing three-week hypofractionated whole-breast radiotherapy is as effective as five weeks, and Ralph Meyer led the CCTG HD.6 trial in Hodgkin lymphoma. Sheila Singh's laboratory studies brain tumour-initiating cells in glioblastoma and medulloblastoma, and Jonathan Bramson's T-cell antigen coupler technology offers an alternative to CAR-T. The centre runs one of Ontario's largest transplant and haematology programmes.
Location
Hamilton, ON, CA
Type
cancer center · McMaster University
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#306 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Juravinski Cancer Centre, including child institutions. 103 works · 1,158 citations · 64% open access · 18% clinical trials · 5% reviews.
Oncology works per year
182022
282023
192024
232025
152026
Most works
- Gregory R. Pond15 works
- Dongsheng Tu10 works
- John R. Goffin9 works
- Elaine McWhirter8 works
- Derek J. Jonker8 works
- Jonathan M. Loree8 works
- Sheila K. Singh7 works
- Amaris Balitsky7 works
- Hagen F. Kennecke7 works
- Mohammed Harb7 works
Most cited
- Radiotherapy trials (hypofractionation)
- Lymphoma trials
- Brain tumour stem cells
- Engineered T cells (TAC)
Chris Hillis
Vice President, Oncology and Site Executive, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences
Malignant haematologyChronic lymphocytic leukaemiaMyeloproliferative neoplasms
Blood cancer specialist who leads the Juravinski Cancer Centre, one of Ontario's largest integrated cancer programmes, as Vice President of Oncology.
Timothy J. Whelan
Professor of Oncology, McMaster University; Radiation Oncologist, Juravinski Cancer Centre
Breast radiotherapyHypofractionationRegional nodal irradiation
Led the Canadian trials that established three-week breast radiotherapy and defined when nodal radiotherapy helps.
Similar pages
- InstitutionThe Ottawa Hospital Cancer Centre / Ottawa Hospital Research Institute
Shares Ontario Health (Cancer Care Ontario), Canadian Cancer Trials Group (CCTG), Trial design, endpoints and cost, CAR-T cell therapy.
- JournalLeukemia & lymphoma
Shares Chris Hillis, Hodgkin lymphoma.
- InstitutionSunnybrook Odette Cancer Centre
Shares Ontario Health (Cancer Care Ontario), Canadian Cancer Trials Group (CCTG), Glioma & glioblastoma, HR-positive / HER2-negative breast cancer.
- PersonWendy Parulekar
Shares Canadian Cancer Trials Group (CCTG), HR-positive / HER2-negative breast cancer.
- TrialNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Shares Canadian Cancer Trials Group (CCTG), IMRT / IGRT (modern external beam).
- TrialRAPID (accelerated partial-breast irradiation)
Shares Canadian Cancer Trials Group (CCTG), IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- TrialCCTG CE.6 / EORTC 26062-22061 (Perry trial)
Shares Canadian Cancer Trials Group (CCTG), Glioma & glioblastoma, IMRT / IGRT (modern external beam).
- TrialNCIC MA.20
Shares Canadian Cancer Trials Group (CCTG), IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.